The anatomical and cellular basis of immune surveillance in the central nervous system

Nature Reviews Immunology

Volumn 12, Issue 9, 2012, Pages 623-635

  Ransohoff, Richard M ^a   Engelhardt, Britta ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR; PADGEM PROTEIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BODY FLUID; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LYMPH NODE; MEMORY T LYMPHOCYTE; MENINX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBARACHNOID SPACE; T LYMPHOCYTE;

AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGIC SURVEILLANCE; LYMPH NODES; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 84866364390     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3265     Document Type: Review

References (101)

1. Weller, R. O., Engelhardt, B. & Phillips, M. J. Lymphocyte targeting of the CNS. A review of afferent and efferent CNS immune pathways. Brain Pathol. 6, 275-288 (1996). (Pubitemid 26246383)
2. Walter, B. A., Valera, V. A., Takahashi, S., Matsuno, K. & Ushiki, T. Evidence of antibody production in the rat cervical lymph nodes after antigen administration into the cerebrospinal fluid. Arch. Histol. Cytol. 69, 37-47 (2006).
3. Prodinger, C. et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 121, 445-458 (2011).
4. Bulloch, K. et al. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508, 687-710 (2008). (Pubitemid 351693557)
5. Karman, J., Ling, C., Sandor, M. & Fabry, Z. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173, 2353-2361 (2004). (Pubitemid 39063091)
6. D'Agostino, P. M. et al. Viral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb. Proc. Natl Acad. Sci. USA 109, 6175-6180 (2012).
7. Miller, S. D., McMahon, E. J., Schreiner, B. & Bailey, S. L. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci.1103, 179-191 (2007). (Pubitemid 46791123)
8. McMahon, E. J., Bailey, S. L. & Miller, S. D. CNS dendritic cells: critical participants in CNS inflammation? Neurochem. Int. 49, 195-203 (2006). (Pubitemid 43867078)
9. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Med. 11, 335-339 (2005). (Pubitemid 40460563)
10. Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188-2197 (2011).
11. Camelo, S., Kezic, J. & McMenamin, P. G. Anterior chamber-associated immune deviation: a review of the anatomical evidence for the afferent arm of this unusual experimental model of ocular immune responses. Clin. Experiment. Ophthalmol. 33, 426-432 (2005). (Pubitemid 44144618)
12. Weller, R. O. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol. 57, 885-894 (1998). (Pubitemid 28477999)
13. Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12-18 (2007). (Pubitemid 44960159)
14. Brabb, T. et al. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192, 871-880 (2000).
15. Ling, E. A., Kaur, C. & Lu, J. Origin, nature, and some functional considerations of intraventricular macrophages, with special reference to the epiplexus cells. Microsc. Res. Tech. 41, 43-56 (1998). (Pubitemid 28160604)
16. Fitzner, D. et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124, 447-458 (2011).
17. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R. & Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25 (2010).
18. Lindahl, P., Johansson, B. R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245 (1997). (Pubitemid 27446080)
19. Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566 (2010).
20. Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557-561 (2010).
21. Abbott, N. J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Rev. Neurosci. 7, 41-53 (2006). (Pubitemid 41828930)
22. Allt, G. & Lawrenson, J. G. Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Brain Res. Rev. 24, 67-76 (1997). (Pubitemid 27293808)
23. Barkalow, F. J., Goodman, M. J., Gerritsen, M. E. & Mayadas, T. N. Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood. 88, 4585-4593 (1996). (Pubitemid 26419141)
24. Yong, T., Zheng, M. Q. & Linthicum, D. S. Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J. Neuroimmunol. 80, 158-164 (1997). (Pubitemid 28015336)
25. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 (2010).
26. Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M. & Rossi, F. M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nature Neurosci. 14, 1142-1149 (2011).
27. Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature Neurosci. 10, 1538-1543 (2007). (Pubitemid 350175883)
28. Ransohoff, R. M. & Perry, V. H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145 (2009).
29. Ransohoff, R. M. & Cardona, A. E. The myeloid cells of the central nervous system parenchyma. Nature 468, 253-262 (2010).
30. Ransohoff, R. M. Microglia and monocytes: 'tis plain the twain meet in the brain. Nature Neurosci. 14, 1098-1100 (2011).
31. Ransohoff, R. M. Microgliosis: the questions shape the answers. Nature Neurosci. 10, 1507-1509 (2007). (Pubitemid 350175863)
32. Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neurosci. 10, 1387-1394 (2007). (Pubitemid 350014685)
33. Trebst, C. et al. CCR1 +CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159, 1701-1710 (2001). (Pubitemid 33062513)
34. Pashenkov, M. et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 122, 106-116 (2002). (Pubitemid 34075496)
35. Kivisakk, P. et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55, 627-638 (2004). (Pubitemid 38544322)
36. Kivisakk, P. et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl Acad. Sci. USA 100, 8389-8394 (2003). (Pubitemid 36842555)
37. Stuve, O. et al. Altered CD4 +CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch. Neurol. 63, 1383-1387 (2006). (Pubitemid 44547548)
38. Stuve, O. et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 59, 743-747 (2006). (Pubitemid 43673151)
39. Giunti, D. et al. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73, 584-590 (2003). (Pubitemid 38040470)
40. Noppen, M. et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am. J. Respir. Crit. Care Med. 162, 1023-1026 (2000).
41. Trampuz, A. et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am. J. Med. 117, 556-562 (2004). (Pubitemid 39304205)
42. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
43. Ransohoff, R. M., Kivisakk, P. & Kidd, G. Three or more routes for leukocyte migration into the central nervous system. Nature Rev. Immunol. 3, 569-581 (2003). (Pubitemid 37328676)
44. Kivisakk, P., Tucky, B., Wei, T., Campbell, J. J. & Ransohoff, R. M. Human cerebrospinal fluid contains CD4+ memory T cells expressing gut-or skin-specific trafficking determinants: relevance for immunotherapy. BMC. Immunol. 7, 8389-8394 (2006).
45. Provencio, J. J., Kivisakk, P., Tucky, B. H., Luciano, M. G. & Ransohoff, R. M. Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients. J. Neuroimmunol. 163, 179-184 (2005). (Pubitemid 40692961)
46. Reboldi, A. et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nature Immunol. 10, 514-523 (2009).
47. Villares, R. et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur. J. Immunol. 39, 1671-1681 (2009).
48. Goldmann, J. et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J. Leukoc. Biol. 80, 797-801 (2006). (Pubitemid 44835898)
49. Furtado, G. C. et al. Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis. J. Immunol. 181, 4648-4655 (2008).
50. Glabinski, A. R., Tani, M., Tuohy, V. K. & Ransohoff, R. M. Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis. Methods Enzymol. 288, 182-190 (1997). (Pubitemid 27443768)
51. Odoardi, F. et al. T cells become licensed in the lung to enter the central nervous system. Nature 30 Aug 2012 (doi:10.1038/nature11337).
52. Chang, T. T. et al. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. Eur. J. Immunol. 33, 2022-2032 (2003). (Pubitemid 37120875)
53. Kawakami, N. et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199, 185-197 (2004). (Pubitemid 38129699)
54. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nature Med. 11, 328-334 (2005). (Pubitemid 40460562)
55. Hickey, W. F., Hsu, B. L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991).
56. Hickey, W. F. & Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292 (1988). (Pubitemid 18061496)
57. Kivisakk, P. et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65, 457-469 (2009).
58. Bartholomaus, I. et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462, 94-98 (2009).
59. Schreiber, T., Shinder, V., Cain, D., Alon, R. & Sackstein, R. Shear flow-dependent integration of apical and subendothelial chemokines in T cell transmigration: implications for locomotion and the "multi-step paradigm". Blood 109, 1381-1386 (2007). (Pubitemid 46239568)
60. Ransohoff, R. M., Man, S. & Ubogu, E. E. "Doing the locomotion" with the multistep paradigm. Blood 109, 1342-1343 (2007).
61. Heppner, F. L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Med. 11, 146-152 (2005). (Pubitemid 40321349)
62. Bergmann, C. C., Lane, T. E. & Stohlman, S. A. Coronavirus infection of the central nervous system: host-virus stand-off. Nature Rev. Microbiol. 4, 121-132 (2006). (Pubitemid 43158155)
63. MacNamara, K. C., Bender, S. J., Chua, M. M., Watson, R. & Weiss, S. R. Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent. J. Virol. 82, 6150-6160 (2008). (Pubitemid 351875097)
64. MacNamara, K. C. & Weiss, S. R. CD8+ T-cell priming during a central nervous system infection with mouse hepatitis virus. Adv. Exp. Med. Biol. 581, 385-390 (2006).
65. Kim, J. V., Kang, S. S., Dustin, M. L. & McGavern, D. B. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457, 191-195 (2009).
66. Wakim, L. M., Woodward-Davis, A. & Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl Acad. Sci. USA 107, 17872-17879 (2010).
67. Wensky, A. K. et al. IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174, 1416-1423 (2005).
68. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A. & Goverman, J. M. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nature Med. 14, 337-342 (2008). (Pubitemid 351347910)
69. Lees, J. R., Golumbek, P. T., Sim, J., Dorsey, D. & Russell, J. H. Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205, 2633-2642 (2008).
70. Carrithers, M. D., Visintin, I., Kang, S. J. & Janeway, C. A. Jr. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123, 1092-1101 (2000). (Pubitemid 30312102)
71. von Andrian, U. H. & Engelhardt, B. α4 integrins as therapeutic targets in autoimmune disease. N. Engl. J. Med. 348, 68-72 (2003). (Pubitemid 36026351)
72. Vajkoczy, P., Laschinger, M. & Engelhardt, B. α4-integrin-VCAM- 1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 108, 557-565 (2001). (Pubitemid 32777735)
73. Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63-66 (1992).
74. Engelhardt, B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural Transm. 113, 477-485 (2006).
75. Khatri, B. O. et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72, 402-409 (2009).
76. Man, S. et al. α4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions. J. Neuroimmunol. 210, 92-99 (2009).
77. Coisne, C., Mao, W. & Engelhardt, B. Cutting edge: natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. J. Immunol. 182, 5909-5913 (2009).
78. Engelhardt, B. & Briskin, M. J. Therapeutic targeting of α4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit? Eur. J. Immunol. 35, 2268-2273 (2005). (Pubitemid 41179748)
79. Hou, J. & Major, E. O. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host. J. Neurovirol. 6, S98-S100 (2000). (Pubitemid 30348921)
80. Ransohoff, R. M. Natalizumab and PML. Nature Neurosci. 8, 1275 (2005). (Pubitemid 41630407)
81. Schwab, N. et al. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology 78, 458-467 (2012).
82. Ransohoff, R. M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31, 711-721 (2009).
83. Brown, D. A. & Sawchenko, P. E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 502, 236-260 (2007). (Pubitemid 46595397)
84. Yoshimura, T. et al. Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein. J. Neurol. Sci. 69, 47-58 (1985). (Pubitemid 15035347)
85. Shin, T. & Matsumoto, Y. A quantitative analysis of CD45Rlow CD4+ T cells in the subarachnoid space of Lewis rats with autoimmune encephalomyelitis. Immunol. Invest. 30, 57-64 (2001). (Pubitemid 32587695)
86. Shin, T., Kojima, T., Tanuma, N., Ishihara, Y. & Matsumoto, Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 56, 171-178 (1995).
87. Peterson, J. W., Bo, L., Mork, S., Chang, A. & Trapp, B. D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389-400 (2001). (Pubitemid 32848742)
88. Kidd, D. et al. Cortical lesions in multiple sclerosis. Brain 122, 17-26 (1999). (Pubitemid 29046269)
89. Bo, L., Vedeler, C., Nyland, H., Trapp, B. & Mork, S. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62, 723-732 (2003). (Pubitemid 36870458)
90. Pomeroy, I. M., Matthews, P. M., Frank, J. A., Jordan, E. K. & Esiri, M. M. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain. 128, 2713-2721 (2005). (Pubitemid 41552954)
91. Merkler, D., Ernsting, T., Kerschenstenier, M., Bruck, W. & Stadelmann, C. A new focal EAE model of cortical demyelination: multiple sclerosis lesions with rapid resolution of inflammation and extensive remyelination. Brain 129, 1972-1983 (2006). (Pubitemid 44289063)
92. Fisher, E., Lee, J. C., Nakamura, K. & Rudick, R. A. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann. Neurol. 64, 255-265 (2008).
93. Lucchinetti, C. F. et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131, 1759-1775 (2008). (Pubitemid 351957454)
94. Pittock, S. J. et al. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J. Neurol. Neurosurg. Psychiatry 76, 1693-1697 (2005). (Pubitemid 41697636)
95. Kivisakk, P. et al. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology 72, 1922-1930 (2009).
96. Schwab, N. et al. Immunological and clinical consequences of treating a patient with natalizumab. Mult. Scler. 18, 335-344 (2012).
97. Ransohoff, R. M. Natalizumab for multiple sclerosis. N. Engl. J. Med. 356, 2622-2629 (2007). (Pubitemid 46961007)
98. Obermeier, B. et al. Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin. J. Neuroimmunol. 233, 245-248 (2011).
99. Obermeier, B. et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nature Med. 14, 688-693 (2008). (Pubitemid 351809541)
100. Magliozzi, R. et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089-1104 (2007). (Pubitemid 47355604)
101. Engelhardt, B. & Ransohoff, R. M. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. (in the press).